Skip to content
WeighLab
Menu

Independent GLP-1 cost & value lab · 2026

Run the numbers before you pick a GLP-1 provider.

We model the real monthly and annual cost of every major GLP-1 telehealth program, then rank them on The Cost-Efficiency Index — value for money, not the lowest teaser rate. 9 providers on the bench. No pay-to-win placement.

9
Providers modeled
6
Index factors
0
Pay-to-win points

Monthly Cost Calculator

Live model
Molecule

Modeled / month

$149

Modeled / year

$1,788

Lowest disclosed semaglutide on our board: Found at $129/mo — but check the full Cost-Efficiency Index before you decide on price alone.

Modeled from each provider's published monthly price at last review. Excludes shipping, labs, and consult fees where not bundled. Prices change — confirm on the provider's site. Not medical advice.

#1 by value — top of the Cost-Efficiency Index

CoreAge Rx

Best value on the board: both molecules at one flat, all-50 price with no teaser step-ups — the lowest true cost of ownership, not the lowest teaser.

The value leaderboard

Best-value GLP-1 providers, measured & ranked

Scored on six factors: normalized cost/month · price transparency · nationwide access · formulation options · clinical oversight · contract flexibility. Partner = available through our affiliate program; editorial review = no commercial relationship. See our disclosure.

#1 by value
#1Grade A

CoreAge Rx

Partner

Best value on the board: both molecules at one flat, all-50 price with no teaser step-ups — the lowest true cost of ownership, not the lowest teaser.

Semaglutide
$149/mo
Tirzepatide
$349/mo
Coverage
All 50 states
Brand-name
Compounded only
  • Flat all-in monthly price — no intro rate that silently triples after month one, so the modeled annual cost is the real cost
  • Both compounded semaglutide and tirzepatide on one account at published prices
  • Available in all 50 states — no coverage gamble
  • Not the rock-bottom sticker price — a pure cheapest-first shopper can find lower teaser tiers
  • No FDA-approved brand-name option (compounded only)
  • Does not yet publicly name its 503A/B pharmacy partner
#2Grade B+

Invigor Medical

Partner

Solid mid-market cost on both molecules from an established operator — good value if you also want a broader metabolic and hormone catalog.

Semaglutide
$199/mo
Tirzepatide
$339/mo
Coverage
Not disclosed
Brand-name
Compounded only
  • Competitive mid-market pricing on both semaglutide and tirzepatide
  • Long-running operator with a broad catalog that can consolidate spend
  • Both molecules published up front for easy cost modeling
  • Does not publish an explicit states-served list, so access is a variable in the model
  • Compounded only
#3Grade B+

ShedRx

Partner

The lowest published tirzepatide cost among our partners, plus an oral/sublingual route — strong cost-per-month for the needle-averse.

Semaglutide
$199/mo
Tirzepatide
$299/mo
Coverage
Not disclosed
Brand-name
Compounded only
  • Lowest published tirzepatide price of our partner tier at $299/mo
  • Offers oral/sublingual forms — more formulation options per dollar
  • Both molecules disclosed for straightforward cost comparison
  • States-served not disclosed
  • Compounded only
#4Grade B

Eden

Partner

You pay a premium per month, but you buy back certainty: all-50 access and high-disclosure clinical oversight that hold their value.

Semaglutide
$239/mo
Tirzepatide
$349/mo
Coverage
All 50 states
Brand-name
Compounded only
  • High transparency — clear supply-chain and clinician disclosure lowers hidden-cost risk
  • Nationwide availability with both molecules disclosed
  • Strong clinical oversight adds value beyond the raw price
  • Premium per-month cost drags its normalized value score
  • Compounded only — no brand-name access
#5Grade B

AgelessRx

Partner

The lowest published semaglutide cost on the board, with some brand-name access — but an undisclosed tirzepatide price leaves a hole in the value model.

Semaglutide
$139/mo
Tirzepatide
Not disclosed
Coverage
Not disclosed
Brand-name
Yes
  • Lowest disclosed semaglutide price at $139/mo
  • Offers some brand-name access
  • Established longevity brand
  • Tirzepatide price not disclosed — you can't fully model total cost
  • States-served not disclosed
#6Grade B+

Found

Editorial review

The cheapest identical price on both molecules nationwide — unbeatable raw cost-per-month, capped only by a coaching subscription you can't fully unbundle.

Semaglutide
$129/mo
Tirzepatide
$129/mo
Coverage
All 50 states
Brand-name
Compounded only
  • Lowest cost-per-month on the board — identical $129 on both molecules
  • Nationwide
  • Strong behavior-change program adds value
  • Coaching subscription can't be unbundled, which reduces contract flexibility
  • Compounded only
#7Grade B

Ro

Editorial review

The widest formulary — brand-name and oral access — but opaque compounded pricing means you can't model the value until you're already in the funnel.

Semaglutide
Not disclosed
Tirzepatide
Not disclosed
Coverage
Multi-state
Brand-name
Yes
  • Brand-name access and insurance support
  • Oral options widen the formulary
  • Polished, well-funded platform
  • Does not publish compounded pricing up front — a blind spot in any cost model
  • Premium positioning
#8Grade B

Hims & Hers

Editorial review

Nationwide reach and a slick app at a mid-market semaglutide price — but an undisclosed tirzepatide price leaves part of the value equation blank.

Semaglutide
$199/mo
Tirzepatide
Not disclosed
Coverage
All 50 states
Brand-name
Compounded only
  • Nationwide
  • Slick app experience
  • Semaglutide priced up front for modeling
  • Tirzepatide pricing not consistently disclosed
  • Compounded supply has drawn industry-wide regulatory scrutiny
#9Grade B−

Henry Meds

Editorial review

A transparent flat-fee pioneer — the pricing is clean and modelable, but it now sits at the higher end, so the value per dollar has slipped.

Semaglutide
$249/mo
Tirzepatide
$349/mo
Coverage
Multi-state
Brand-name
Compounded only
  • Simple, transparent flat-fee model that's easy to model
  • Well-established brand
  • Both molecules disclosed
  • Higher per-month cost than many newer entrants weakens value
  • Compounded only

Pricing, states and verification facts reflect each provider's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on the provider's site. Not medical advice.

Value, not teaser price

We normalize cost against what you actually get — both molecules, flat pricing, real access — so the cheapest sticker doesn't automatically win.

Honest low scores

Opaque pricing and coverage gaps drag scores down, and we say exactly why. A leaderboard that flatters everyone is useless.

No pay-to-win

Affiliate status is disclosed on every card and never adds a single point to the Cost-Efficiency Index.